Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Short- and long-term survival after severe acute pancreatitis: A retrospective 17 years' cohort study from a single center.

Husu HL, Leppäniemi AK, Lehtonen TM, Puolakkainen PA, Mentula PJ.

J Crit Care. 2019 Oct;53:81-86. doi: 10.1016/j.jcrc.2019.06.001. Epub 2019 Jun 4.

PMID:
31202162
2.

Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review.

Räihä MR, Puolakkainen PA.

Chronic Dis Transl Med. 2018 Sep 3;4(3):156-163. doi: 10.1016/j.cdtm.2018.07.001. eCollection 2018 Sep.

3.

Toward a Consensus on Centralization in Surgery.

Vonlanthen R, Lodge P, Barkun JS, Farges O, Rogiers X, Soreide K, Kehlet H, Reynolds JV, Käser SA, Naredi P, Borel-Rinkes I, Biondo S, Pinto-Marques H, Gnant M, Nafteux P, Ryska M, Bechstein WO, Martel G, Dimick JB, Krawczyk M, Oláh A, Pinna AD, Popescu I, Puolakkainen PA, Sotiropoulos GC, Tukiainen EJ, Petrowsky H, Clavien PA.

Ann Surg. 2018 Nov;268(5):712-724. doi: 10.1097/SLA.0000000000002965.

PMID:
30169394
4.

Increasing the Inflammatory Competence of Macrophages with IL-6 or with Combination of IL-4 and LPS Restrains the Invasiveness of Pancreatic Cancer Cells.

Salmiheimo AN, Mustonen HK, Vainionpää SA, Shen Z, Kemppainen EA, Seppänen HE, Puolakkainen PA.

J Cancer. 2016 Jan 1;7(1):42-9. doi: 10.7150/jca.12923. eCollection 2016.

5.

Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis.

Lindström OK, Tukiainen EM, Kylänpää ML, Mentula PJ, Puolakkainen PA, Wartiovaara-Kautto UM, Repo H, Petäjä JM.

Pancreatology. 2011;11(6):557-66. doi: 10.1159/000333481. Epub 2011 Dec 29.

PMID:
22213026
6.

Inflammation and immunosuppression in severe acute pancreatitis.

Kylänpää ML, Repo H, Puolakkainen PA.

World J Gastroenterol. 2010 Jun 21;16(23):2867-72. Review.

7.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
8.

Altered tissue repair in hevin-null mice: inhibition of fibroblast migration by a matricellular SPARC homolog.

Sullivan MM, Puolakkainen PA, Barker TH, Funk SE, Sage EH.

Wound Repair Regen. 2008 Mar-Apr;16(2):310-9. doi: 10.1111/j.1524-475X.2008.00370.x.

PMID:
18318815
9.

Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study.

Rau BM, Kemppainen EA, Gumbs AA, Büchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG.

Ann Surg. 2007 May;245(5):745-54.

10.

Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study.

Rau BM, Frigerio I, Büchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK.

Arch Surg. 2007 Feb;142(2):134-42.

PMID:
17309964
11.

Intron 1 retaining cyclooxygenase 1 splice variant is induced by osmotic stress in human intestinal epithelial cells.

Nurmi JT, Puolakkainen PA, Rautonen NE.

Prostaglandins Leukot Essent Fatty Acids. 2005 Nov;73(5):343-50.

PMID:
16115753
12.

SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.

Puolakkainen PA, Bradshaw AD, Brekken RA, Reed MJ, Kyriakides T, Funk SE, Gooden MD, Vernon RB, Wight TN, Bornstein P, Sage EH.

J Histochem Cytochem. 2005 May;53(5):571-81.

PMID:
15872050
13.
14.

Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.

Barker TH, Framson P, Puolakkainen PA, Reed M, Funk SE, Sage EH.

Am J Pathol. 2005 Mar;166(3):923-33.

15.
16.

Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models.

Halonen KI, Leppäniemi AK, Lundin JE, Puolakkainen PA, Kemppainen EA, Haapiainen RK.

Pancreatology. 2003;3(4):309-15.

PMID:
12890993
17.

Long-term health-related quality of life in survivors of severe acute pancreatitis.

Halonen KI, Pettilä V, Leppäniemi AK, Kemppainen EA, Puolakkainen PA, Haapiainen RK.

Intensive Care Med. 2003 May;29(5):782-6. Epub 2003 Apr 9.

PMID:
12684744
18.

Multiple organ dysfunction associated with severe acute pancreatitis.

Halonen KI, Pettilä V, Leppäniemi AK, Kemppainen EA, Puolakkainen PA, Haapiainen RK.

Crit Care Med. 2002 Jun;30(6):1274-9.

PMID:
12072681
19.

Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis.

Kylänpää-Bäck ML, Takala A, Kemppainen EA, Puolakkainen PA, Leppäniemi AK, Karonen SL, Orpana A, Haapiainen RK, Repo H.

Crit Care Med. 2001 Jan;29(1):63-9.

PMID:
11176162
20.

Severe acute pancreatitis: prognostic factors in 270 consecutive patients.

Halonen KI, Leppaniemi AK, Puolakkainen PA, Lundin JE, Kemppainen EA, Hietaranta AJ, Haapiainen RK.

Pancreas. 2000 Oct;21(3):266-71.

PMID:
11039471
21.

Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.

Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA.

Lancet. 2000 Jun 3;355(9219):1955-60.

PMID:
10859041
22.

Advances in the laboratory diagnostics of acute pancreatitis.

Kemppainen EA, Hedström JI, Puolakkainen PA, Haapiainen RK, Stenman UH.

Ann Med. 1998 Apr;30(2):169-75. Review.

PMID:
9667795
23.

Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis.

Kemppainen EA, Hedström JI, Puolakkainen PA, Sainio VS, Haapiainen RK, Perhoniemi V, Osman S, Kivilaakso EO, Stenman UH.

N Engl J Med. 1997 Jun 19;336(25):1788-93.

24.

Incorrect estimation of severity of acute pancreatitis by contrast-enhanced computed tomography.

Sainio VS, Puolakkainen PA, Kemppainen EJ, Kivisaari L, Haapiainen RK, Schröder TM, Lehtonen EI, Kivilaakso EO.

Ann Chir Gynaecol. 1997;86(3):214-21.

PMID:
9435932
25.

Acceleration of wound healing in aged rats by topical application of transforming growth factor-beta(1).

Puolakkainen PA, Reed MJ, Gombotz WR, Twardzik DR, Abrass IB, Sage HE.

Wound Repair Regen. 1995 Jul-Sep;3(3):330-9.

PMID:
17173560
26.

The enhancement in wound healing by transforming growth factor-beta 1 (TGF-beta 1) depends on the topical delivery system.

Puolakkainen PA, Twardzik DR, Ranchalis JE, Pankey SC, Reed MJ, Gombotz WR.

J Surg Res. 1995 Mar;58(3):321-9.

PMID:
7885030
27.

Novel delivery system for inducing quiescence in intestinal stem cells in rats by transforming growth factor beta 1.

Puolakkainen PA, Ranchalis JE, Gombotz WR, Hoffman AS, Mumper RJ, Twardzik DR.

Gastroenterology. 1994 Nov;107(5):1319-26.

PMID:
7926496
28.

Stimulation of bone healing by transforming growth factor-beta 1 released from polymeric or ceramic implants.

Gombotz WR, Pankey SC, Bouchard LS, Phan DH, Puolakkainen PA.

J Appl Biomater. 1994 Summer;5(2):141-50.

PMID:
10172073
29.

The effect of sterilization on transforming growth factor beta isolated from demineralized human bone.

Puolakkainen PA, Ranchalis JE, Strong DM, Twardzik DR.

Transfusion. 1993 Aug;33(8):679-85.

PMID:
8342237
30.

Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency.

Rämö OJ, Puolakkainen PA, Seppälä K, Schröder TM.

Scand J Gastroenterol. 1989 Aug;24(6):688-92.

PMID:
2479083
31.

Fatal air embolism as a complication of laser-induced hyperthermia.

Schröder TM, Puolakkainen PA, Hahl J, Rämö OJ.

Lasers Surg Med. 1989;9(2):183-5.

PMID:
2716463
32.

Supplemental Content

Loading ...
Support Center